Back to top

Insulet Corporation (PODD)

(Delayed Data from NSDQ)

$282.45 USD


+0.85 (0.30%)

Updated Jun 11, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
5Strong Sell3.06%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (191 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). It is worn on the body for approximately three days at a time and allows virtually pain-free automated cannula insertion and blood glucose meter integration.

The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes, which the company has been selling since 2005. The Omnipod ...

General Information

Insulet Corporation


ACTON, MA 01720

Phone: 978-600-7000

Fax: 978-600-0120



Industry Medical - Products
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2021
Next EPS Date 8/5/2021

EPS Information

Current Quarter EPS Consensus Estimate 0.12
Current Year EPS Consensus Estimate 0.71
Estimated Long-Term EPS Growth Rate NA
Next EPS Report Date 8/5/2021

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 281.60
52 Week High 306.46
52 Week Low 177.45
Beta 0.68
20 Day Moving Average 567,072.13
Target Price Consensus 276.06


% Price Change
4 Week 21.53
12 Week 8.21
YTD 10.49
% Price Change Relative to S&P 500
4 Week 19.42
12 Week -0.31
YTD -2.29
Share Information
Shares Outstanding (millions) 66.27
Market Capitalization (millions) 18,718.31
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E (F1) 399.22
Trailing 12 Months 2,172.69
PEG Ratio NA
EPS Growth
vs. Previous Year 100.00%
vs. Previous Quarter 100.00%
Sales Growth
vs. Previous Year 27.42%
vs. Previous Quarter 2.52%
Price Ratios
Price/Book 31.95
Price/Cash Flow 299.38
Price / Sales 19.52
3/31/21 1.52
12/31/20 1.49
9/30/20 8.94
3/31/21 0.50
12/31/20 0.43
9/30/20 2.07
Current Ratio
3/31/21 6.42
12/31/20 6.01
9/30/20 6.62
Quick Ratio
3/31/21 5.51
12/31/20 5.27
9/30/20 5.91
Operating Margin
3/31/21 0.93
12/31/20 0.75
9/30/20 3.33
Net Margin
3/31/21 0.93
12/31/20 0.75
9/30/20 3.33
Pre-Tax Margin
3/31/21 1.31
12/31/20 1.07
9/30/20 4.03
Book Value
3/31/21 8.84
12/31/20 9.16
9/30/20 9.02
Inventory Turnover
3/31/21 2.43
12/31/20 2.69
9/30/20 2.94
3/31/21 1.80
12/31/20 1.73
9/30/20 1.55
Debt to Capital
3/31/21 64.24
12/31/20 63.36
9/30/20 60.76